XNK Therapeutics to present at 2nd Annual Innate Killer Europe Summit in October

XNK Therapeutics AB announced that Anna-Karin Maltais, Chief Scientific Officer, will be speaking at the 2nd Annual Innate Killer Europe Summit in London on October 18.

Scroll to Top